226 - 250 of 8142 Results
Title
Year
- Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts2024OPENTitle: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00789-wBest OA location URL: https://doi.org/10.1038/s41531-024-00789-wCitation Count: 4
- VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A12024OPENTitle: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1Journal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202311189Citation Count: 2
- Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort study2024OPENTitle: Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort studyJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 46Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-024-07738-8Citation Count: 0
- Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease2024OPENTitle: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's DiseaseJournal Name: Journal of Integrative NeurosciencePublisher: IMR PressVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.31083/j.jin2309178Citation Count: 0
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1481End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Citation Count: 0
- Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin America2024OPENTitle: Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin AmericaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14214Citation Count: 0
-
OPENTitle: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PETJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-52298-2Citation Count: 1
- Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome2024OPENTitle: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.30019Citation Count: 2
-
OPENTitle: Activation of parkin by a molecular glueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-024-51889-3Citation Count: 5
-
OPENTitle: An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s diseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2024.1379984Citation Count: 4
- Head-up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case Report2024OPENTitle: Head-up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case ReportJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 16Issue #: 1Start Page: 256End Page: 261Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1159/000541424Citation Count: 0
- How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?2024OPENTitle: How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-71598-7Citation Count: 1
- NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations2024OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Citation Count: 11
- Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progression2024OPENTitle: Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Citation Count: 0
-
OPENTitle: A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani FamilyJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1203End Page: 1203Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.3390/genes15091203Citation Count: 1
- Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytes2024OPENTitle: Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytesJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41380-024-02746-8Citation Count: 0
- Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W2024OPENTitle: Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 18Start Page: 1540End Page: 1540Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13181540Citation Count: 1
- RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease2024OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkae776Citation Count: 0
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Citation Count: 2
-
RESTRICTEDTitle: Validating New Symptom Emergence as a Patient-Centric Outcome Measure for PD Clinical TrialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Citation Count: 0
- Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer2024OPENTitle: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancerJournal Name: Nature MetabolismPublisher: Springer Science and Business Media LLCVol: 6Issue #: 9Start Page: 1695End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42255-024-01118-4Citation Count: 8
- SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers Initiative2024OPENTitle: SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers InitiativeJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1185End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes15091185Citation Count: 0
-
RESTRICTEDTitle: Visual hallucinations in Parkinson's disease: spotlight on central cholinergic dysfunctionJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae289Citation Count: 0
- A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease2024OPENTitle: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549Citation Count: 0
- Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials2024OPENTitle: Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII TrialsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1243End Page: 1255Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240035Citation Count: 0